The plant equivalents are the phytosterols, such as -sitosterol, stigmasterol, and brassicasterol; the latter compound is also used as a biomarker for algal growth.
The biomarker cut point will need to be validated in the larger study population, but seems to identify patients most likely to respond to pembrolizumab well.
